{"id":"NCT02960893","sponsor":"Biohaven Pharmaceuticals, Inc.","briefTitle":"Trial in Adult Subjects With Spinocerebellar Ataxia","officialTitle":"A Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of Troriluzole in Adult Subjects With Spinocerebellar Ataxia","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-12-15","primaryCompletion":"2017-08-18","completion":"2024-09-20","firstPosted":"2016-11-10","resultsPosted":"2020-08-14","lastUpdate":"2025-01-30"},"enrollment":141,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Spinocerebellar Ataxias","Spinocerebellar Ataxia Genotype Type 1","Spinocerebellar Ataxia Genotype Type 2","Spinocerebellar Ataxia Genotype Type 3","Spinocerebellar Ataxia Genotype Type 6","Spinocerebellar Ataxia Genotype Type 7","Spinocerebellar Ataxia Genotype Type 8","Spinocerebellar Ataxia Genotype Type 10"],"interventions":[{"type":"DRUG","name":"Troriluzole","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Troriluzole","otherNames":[]}],"arms":[{"label":"Troriluzole","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary purpose of this study is to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in subjects with spinocerebellar ataxia (SCA).","primaryOutcome":{"measure":"Change From Baseline in Total Score on the Scale for the Assessment and Rating of Ataxia (SARA) at Randomization Phase Week 8","timeFrame":"Baseline, Randomization Phase Week 8","effectByArm":[{"arm":"Troriluzole - Randomization Phase","deltaMin":-0.81,"sd":1.7653},{"arm":"Placebo - Randomization Phase","deltaMin":-1.059,"sd":2.3221}],"pValues":[{"comp":"OG000 vs OG001","p":"0.519"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":18,"countries":["United States"]},"refs":{"pmids":["34115419"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":71},"commonTop":["Fall","Nausea","Dizziness","Fatigue","Headache"]}}